Liquet Medical Inc., a pioneering medical device company committed to advancing patient care through innovative technologies, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration...

Biomedical engineering professor Silvia Salinas Blemker, widely regarded as a leader in her field, has been elected as a Fellow of the National Academy of Inventors, recognizing her ability to turn...

TearSolutions, a Charlottesville biotech that is developing treatments for ocular surface diseases, has raised a $3 million Series B round. TearSolutions Inc., a Charlottesville biotech that is developing treatments for...

The subcutaneous ketamine-loaded implant is being developed as a treatment for fibromyalgia and chronic pain. US-based Silo Pharma has partnered with North Carolina-based Kymanox to jointly design and develop a...

Aechelon Unveils First-of-its-kind Image Generator Interface for Luna Labs’ 3WAVES, Stimulating Virtual Motion Sensations of Yaw, Pitch, and Roll Orlando, FL (USA) — 25 November 2024 – Aechelon Technology Inc. announced today...

Shiny gold letters hang on AgroSpheres’ lobby wall spelling out the start-up’s vision: a future built by nature’s technologies. At the opposite end of the facility sits a 1,300 m2...

NEWTON, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of...

Codevelop and Commercialize Category-Defining Broad-Spectrum Bioinsecticide Charlottesville, VA and Limburgerhof, Germany — October 21, 2024 — AgroSpheres, a biotechnology leader in sustainable crop protection and crop health, and BASF, a...

CHARLOTTESVILLE, VA, OCTOBER 8, 2024 — RIVANNA®, developers of imaging-based medical solutions, has announced the launch of the first multi-site study employing the Accuro® XV musculoskeletal imaging system. This milestone...

CHARLOTTESVILLE, Va. and SAN FRANCISCO, Sept. 30, 2024 /PRNewswire/ — Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to improving metabolic health, today announced new clinical data from the Phase 2a HuMAIN study of...

CHARLOTTESVILLE, VA, September 30, 2024 – AgroSpheres Inc. (AGS), a biotechnology leader in sustainable crop protection and crop health, today announced the final close of a $37 million Series B funding round led by...

NEWTON, Mass., and BASEL, Switzerland, Sept. 26, 2024 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta (Aβ) oligomers...